“Matching-Adjusted Indirect Comparison of the Efficacy of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Beyond Week 16”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s319. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2400.